BRPI0417797A - soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos - Google Patents

soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos

Info

Publication number
BRPI0417797A
BRPI0417797A BRPI0417797-5A BRPI0417797A BRPI0417797A BR PI0417797 A BRPI0417797 A BR PI0417797A BR PI0417797 A BRPI0417797 A BR PI0417797A BR PI0417797 A BRPI0417797 A BR PI0417797A
Authority
BR
Brazil
Prior art keywords
blood serum
producing
methods
biologically active
active blood
Prior art date
Application number
BRPI0417797-5A
Other languages
English (en)
Inventor
Vitali A Shestakov
Original Assignee
Owen Holding Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2003/014578 external-priority patent/WO2005058333A1/de
Application filed by Owen Holding Ltd filed Critical Owen Holding Ltd
Publication of BRPI0417797A publication Critical patent/BRPI0417797A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/141—Feedstock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"SORO SANGUìNEO BIOLOGICAMENTE ATIVO, MéTODOS PARA PRODUZI-LO E SEUS USOS". A presente invenção refere-se a um método para preparar um produto do soro sanguíneo, o produto do soro sanguíneo e uma composição farmacêutica compreendendo o referido produto do soro sanguíneo, assim como seus usos no tratamento de várias doenças e condições, incluindo ataques epilépticos e apoplexia.
BRPI0417797-5A 2003-12-18 2004-12-20 soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos BRPI0417797A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2003/014578 WO2005058333A1 (de) 2003-12-18 2003-12-18 Methode zur gewinnung eines biologisch aktiven mit elektroschock behandelten blutserums und seine verwendung
US61973804P 2004-10-18 2004-10-18
PCT/EP2004/014510 WO2005058889A2 (en) 2003-12-18 2004-12-20 Biological active blood serum obtained by electrostimulation

Publications (1)

Publication Number Publication Date
BRPI0417797A true BRPI0417797A (pt) 2007-03-20

Family

ID=37873237

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417797-5A BRPI0417797A (pt) 2003-12-18 2004-12-20 soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos

Country Status (7)

Country Link
EP (1) EP1699470A2 (pt)
JP (1) JP2007514706A (pt)
AU (1) AU2004299279B2 (pt)
BR (1) BRPI0417797A (pt)
CA (1) CA2546979A1 (pt)
RU (1) RU2364404C2 (pt)
WO (1) WO2005058889A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1714659A1 (en) * 2005-04-18 2006-10-25 OWEN Holding LTD A biological active blood serum for the treatment of stroke
EP1797890A1 (en) * 2005-12-09 2007-06-20 OWEN Holding LTD A method for obtaining a biologically active fraction of blood serum treated with gamma irradiation and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
RU2236238C2 (ru) * 2000-02-29 2004-09-20 Шестаков Виталий Александрович Способ получения биологически активной субстанции из сыворотки крови
EP1292359A4 (en) * 2000-05-22 2005-03-30 Merck & Co Inc SYSTEM AND METHOD FOR EVALUATING THE EFFICACY OF A PHARMACEUTICAL AGENT DELIVERY DEVICE

Also Published As

Publication number Publication date
WO2005058889A3 (en) 2005-08-04
AU2004299279B2 (en) 2010-04-08
CA2546979A1 (en) 2005-06-30
WO2005058889A2 (en) 2005-06-30
RU2364404C2 (ru) 2009-08-20
EP1699470A2 (en) 2006-09-13
RU2006121488A (ru) 2007-12-27
JP2007514706A (ja) 2007-06-07
AU2004299279A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
PE20050255A1 (es) Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos
NO20075136L (no) Nye liposompreparater
CR8380A (es) Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos
ECSP055739A (es) Anticuerpos de neutralización contra gdf-8, y sus usos
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
SMT201300095B (it) Uso dell'estere etilico dell'acido eicosapentaenoico per trattare l'ipertrigliceridemia
GB0211649D0 (en) Organic compounds
WO2007002516A3 (en) Improved dosage forms for movement disorder treatment
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
BRPI0408863A (pt) composto, composição farmacêutica, método para tratar doenças, e, uso de um composto.
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
TW200505880A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
BR112023018237A2 (pt) Fenalquilaminas e métodos para fabricação e uso das mesmas
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
BRPI0416188A (pt) formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas
WO2005123651A8 (en) L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
BRPI0417797A (pt) soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
DE602006009848D1 (de) Die regeneration von neuronen des zentralen nervensystems stimulierende peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
DE602006003652D1 (de) Ocaperidonsalze und pharmazeutische zusammensetzungen, die diese enthalten

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.